ESG

The 2026 MIECF saw a surge in deals and global participation, showcasing Macao's strategic pivot to a key player in the green economy and technology.

New Medicare billing codes for the biosimilar Tyenne are now in effect, simplifying reimbursement and aiming to improve access for severe COVID-19 patients.

A Sarasota innovator challenges orthopedic giants with a resorbable device that works with the body, promising faster, better patient recovery.

A new maternal blood test claims over 97% accuracy in predicting autism risk, offering hope for early intervention while igniting a fierce ethical debate.

1 Hotel Hanalei Bay blends cutting-edge biohacking with the raw power of nature, aiming to redefine luxury wellness. Is this the future of health travel?

New federal data validates a high-grade rare earth deposit in Montana, a critical step in the US race to break China's grip on strategic minerals.

With its European trial launch, Kainova's DT-7012 aims to disarm cancer's bodyguards, offering new hope for patients with advanced solid tumors.

A new report argues companies have the tools but lack the strategy, making organizational misalignment the top cybersecurity threat heading into 2026.

Eli Lilly's new once-daily oral GLP-1, Foundayo, is now on telehealth platform Ro, offering a convenient, needle-free alternative to injectable drugs.

Two industry titans are pouring €1 billion into a new joint venture, aiming to capitalize on Europe's booming e-commerce and supply chain shifts.

A Swiss biotech's novel antibiotic has entered human trials with new funding, offering a fresh hope against the world's most dangerous superbugs.

With revenue doubling to ₹22.5 crore and a ₹50 crore target, Relux Electric is accelerating its build-out of a sustainable EV charging network across India.

As new software gives schools full visibility into student iPads, educators gain powerful safety tools, but critics warn of a new era of classroom surveillance.

Optro's inaugural EMEA conference signals a major push into Europe's complex GRC market, focusing on AI governance and transforming risk into opportunity.

Satri-cel, the world's first CAR-T therapy for solid tumors, is set to launch in China, offering a powerful new weapon against advanced stomach cancers.

Aptar Digital Health and Enable Injections are pairing the enFuse® wearable injector with a new digital app to transform self-care for chronic diseases.

As Watts Water Technologies preps its Q1 2026 report, investors watch for clues on market health, strategic growth, and the impact of new regulations.

Following a massive stock surge, Forte Biosciences is raising $150M. The funds are crucial for a pivotal year of clinical trials for its autoimmune drug.

The retailer posts modest annual growth despite a tough Q4, as international gains and efficiency drives offset major headwinds in its Canadian operations.

A Texas firm opens a plant for a non-toxic chemical that boosts oil output and could turn old wells into a new source of critical minerals.